Looks like a high growth company.
Why does it show 50% lower next quarter and a small YOY decline next year?
If it is indeed in decline does it deserve high price multipliers it has now?
Why did the directors resign, any scoop?
And finally when there is enough cash reserve and 200 million in cash flow, why would they borrow?
Thanks for replies in advance.
And good luck
OR slowly drift towards 6.5
It may not be fraudulent but it is misleading at least.
I also noticed, even after two days of huge volume not all 30 millions shorts are covered.
That means, there is a group still expecting this stock to go down further.
Yes, I did check their website.
That is something I should have mentioned in the first message itself.
There is hardly any business information.
It is all about finances and revenue and other numbers.
News and presentations are also related to financing but none related to science.
Yes normally dividends are paid from profit, but PDL seems to borrow to do that.
A biotech company, not near MIT or Stanford, but near Reno. It does not even look like an office building.
Half a billion in debt but still pays dividend,
50% growth but still a PE of 5
~300 million in profit but just 10 employees.
2 million in daily volume not none available to short.
When the secondary offering is at 54 why did it jump to 60 suddenly?
Shouldn't such an offering dilute earnings or at least the the base for stock price?
With negative cash flow, ~100M in revenue, 7 times as much debt how can it be a 4B company?
What am I missing?